More recently, growing interest has been paid to developing natural products-based agents to revers P-gp-mediated multidrug resistance in cancer cells because of their low toxicity, selective behavior, and ability to target various signal transduction pathways [32,47]. This evidence concerns the gene PGP and cancer.